Open AccessImmunogenicity and safety of BNT162b2 COVID‐19 vaccine in a chronic lymphocytic leukaemia patient
Author(s) -
Chiara Agrati,
Concetta Castilletti,
Alessandra Sacchi,
Francesca Colavita,
Maria Rosaria Capobianchi,
Vincenzo Puro,
Emanuele Nicastri,
Giuseppe Ippolito,
Michele Bibas
Publication year - 2021
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/jcmm.16565
Subject(s) - medicine , immunogenicity , immunology , vaccination , chronic lymphocytic leukemia , population , disease , immune system , antibody , leukemia , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom